Where can visitors find more info? About Jurgi Camblong Jurgi Camblong is a entrepreneur whose schooling was in biochemistry and molecular biology. He keeps a PhD in Existence Sciences and an EMBA in general management of Technology . This year 2010, he entered the start-up picture, getting the CEO of Gene Predictis SA. In 2011, he founded Sophia Genetics SA with Dr. Pierre Prof and Hutter. Lars Steinmetz. Since that time he has been effectively leading the advancement of the company.. BRCA1/2 analysis: an interview with Jurgi Camblong, CEO of Sophia Genetics By April Cashin-Garbutt Interview conducted, BA Hons insights from industryJurgi CamblongCEO of Sophia Genetics Make sure you can you provide a brief launch to the BRCA1 and BRCA2 genes? BRCA1 and BRCA2 genes are two of the very most well studied genes in the cancer field.Sinai Hospital in NY, NY, researchers conducted a retrospective research of sufferers who underwent cardiac medical procedures at Mt. Sinai INFIRMARY between January 1998 and December 2004, and identified 27 sufferers who had cirrhosis. Of the, 18 individuals had cardiac surgery with cardiopulmonary bypass while the additional 9 had surgery without using the heart-lung machine. The results showed that medical center mortality increased significantly based on the Child-Pugh classification, with a mortality price of 10 % for all those with class A, 18 % for all those with course B, and 67 % for all those with class C. Postoperative complications were higher in class B and C than in class A also. There was no correlation between mortality and the MELD score, however.